205 related articles for article (PubMed ID: 27067884)
21. Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.
Kumar M; Cao W; McDaniel JK; Pham HP; Raju D; Nawalinski K; Frangos S; Kung D; Zager E; Kasner SE; Levine JM; Zheng XL
Thromb Haemost; 2017 Apr; 117(4):691-699. PubMed ID: 28102428
[TBL] [Abstract][Full Text] [Related]
22. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study.
Smith A; Patterson C; Yarnell J; Rumley A; Ben-Shlomo Y; Lowe G
Circulation; 2005 Nov; 112(20):3080-7. PubMed ID: 16286603
[TBL] [Abstract][Full Text] [Related]
23. Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women.
Mannucci PM; Bernardinelli L; Foco L; Galli M; Ribichini F; Tubaro M; Peyvandi F
J Thromb Haemost; 2005 Feb; 3(2):280-6. PubMed ID: 15670033
[TBL] [Abstract][Full Text] [Related]
24. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
[TBL] [Abstract][Full Text] [Related]
25. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
Wannamethee SG; Sattar N; Rumley A; Whincup PH; Lennon L; Lowe GD
Diabetes Care; 2008 May; 31(5):995-1000. PubMed ID: 18235054
[TBL] [Abstract][Full Text] [Related]
26. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.
Prasad RN; Koh SC; Viegas OA; Ratnam SS
Clin Appl Thromb Hemost; 1999 Jan; 5(1):60-70. PubMed ID: 10725985
[TBL] [Abstract][Full Text] [Related]
27. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
28. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.
Thøgersen AM; Nilsson TK; Weinehall L; Boman K; Eliasson M; Hallmans G; Jansson JH
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):340-6. PubMed ID: 19357504
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
[TBL] [Abstract][Full Text] [Related]
30. The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia.
Koh SC; Singh K
J Thromb Haemost; 2007 Jan; 5(1):133-8. PubMed ID: 17010149
[TBL] [Abstract][Full Text] [Related]
31. Von Willebrand factor and ADAMTS13 plasma in older patients with high CHA2DS2-VASc Score with and without atrial fibrillation.
Zhang F; Yang XC; Jia XW; Tang XH; Wang Z; Wang ZQ
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4907-4912. PubMed ID: 29164570
[TBL] [Abstract][Full Text] [Related]
32. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
[TBL] [Abstract][Full Text] [Related]
33. Risk of intracerebral hemorrhage after thrombolysis in patients with asymptomatic hemorrhage on T2*.
Aoki J; Shibazaki K; Saji N; Uemura J; Sakamoto Y; Kimura K
Cerebrovasc Dis; 2014; 38(2):107-16. PubMed ID: 25277866
[TBL] [Abstract][Full Text] [Related]
34. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates.
Strauss T; Elisha N; Ravid B; Rosenberg N; Lubetsky A; Levy-Mendelovich S; Morag I; Nowak Göttl U; Kenet G
Blood Cells Mol Dis; 2017 Sep; 67():14-17. PubMed ID: 28087247
[TBL] [Abstract][Full Text] [Related]
35. Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study.
Kaplan RC; McGinn AP; Baird AE; Hendrix SL; Kooperberg C; Lynch J; Rosenbaum DM; Johnson KC; Strickler HD; Wassertheil-Smoller S
J Stroke Cerebrovasc Dis; 2008; 17(6):344-55. PubMed ID: 18984425
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic value of endothelial dysfunction and von Willebrand factor in acute and chronic hemispheric intracerebral hemorrhage].
Gusev EI; Martynov MY; Koltsov IA; Yasamanova AN; Fidler MS; Tshukin IA
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(8. Vyp. 2):46-52. PubMed ID: 31825362
[TBL] [Abstract][Full Text] [Related]
37. Rebalanced hemostasis in patients with idiopathic thrombocytopenic purpura.
Kim WH; Park JB; Jung CW; Kim GS
Platelets; 2015; 26(1):38-42. PubMed ID: 24433238
[TBL] [Abstract][Full Text] [Related]
38. Increased serum vWF and sVCAM-1 levels are associated with late or very late angiographic stent thrombosis after sirolimus-eluting stent implantation.
Jin C; Lu L; Zhu ZB; Zhang RY; Zhang Q; Du R; Ding FH; Chen QJ; Shen WF
Coron Artery Dis; 2010 Aug; 21(5):273-7. PubMed ID: 20508517
[TBL] [Abstract][Full Text] [Related]
39. Effects of rhG-CSF plus dexamethasone on hemostatic parameters in healthy granulocyte donors: role of u-PA and nitric oxide.
Ekmekçi OB; Oztürk G; Ekmekçi H; Atay D; Yanaşik M; Anak S; Devecioğlu O
Clin Appl Thromb Hemost; 2009 Dec; 15(6):689-94. PubMed ID: 18544592
[TBL] [Abstract][Full Text] [Related]
40. Peripheral monocyte count is associated with case fatality after intracerebral hemorrhage.
Adeoye O; Walsh K; Woo JG; Haverbusch M; Moomaw CJ; Broderick JP; Kissela BM; Kleindorfer D; Flaherty ML; Woo D
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e107-11. PubMed ID: 24119622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
